| 摘要 |
The present invention relates to a composition comprising a plurality of cDNAs which are expressed during adipocyte differentiation, particularly in disorders associated with obesity and type II diabetes, and which may be used, in their entirety or in part, to diagnose, to stage, to treat, or to monitor the progression or treatment of such disorders.
|
